FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)
PHASE1
This Phase 1 study will evaluate the safety and tolerability of \[Ga-68\]-P...
(68)Ga-FAPI PET/CT in Patients With ANCA-associated Vasculitis
N/A
Pulmonary and renal involvement are the most common clinical manifestations...
Status
Recruiting
Location
Ruiiin Hospital Shanghai JiaoTong University School of Medicine
Start Date
2025-09-01
Trial ID
NCT07151521
Clinical Study of 18F-FAPI-RGD in Interstitial Lung Disease Associated With Connective Tissue Disease
N/A
The goal of this observational study is to examine clinical utility of 18F-...
Status
Unknown
Location
Sichuan Provincial People's Hospital
Start Date
2023-08-16
Trial ID
NCT06143540
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
PHASE2
This study is a Phase 2/3, prospective, multicenter, open-label, non-random...